Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Strata Skin Sciences ( (SSKN) ).
STRATA Skin Sciences, Inc. announced an equity distribution agreement with Ladenburg Thalmann & Co. Inc. for the sale of up to $11 million in common stock shares. This agreement, initially registered in 2021 and updated in 2024, allows for future offerings, potentially impacting the company’s market operations and investor relations.
The most recent analyst rating on (SSKN) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Strata Skin Sciences stock, see the SSKN Stock Forecast page.
Spark’s Take on SSKN Stock
According to Spark, TipRanks’ AI Analyst, SSKN is a Neutral.
The overall stock score of 47 reflects significant financial challenges, including persistent losses and a negative P/E ratio. While there are some positive technical indicators and strategic initiatives from the earnings call, these are overshadowed by the company’s ongoing profitability issues and valuation concerns.
To see Spark’s full report on SSKN stock, click here.
More about Strata Skin Sciences
STRATA Skin Sciences, Inc. operates in the medical technology industry, focusing on dermatological treatments and products.
Average Trading Volume: 4,511,200
Technical Sentiment Signal: Sell
Current Market Cap: $10.54M
Learn more about SSKN stock on TipRanks’ Stock Analysis page.